Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kamaneh Montazeri, M.D.

Concepts (49)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Kamaneh Montazeri's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Kamaneh Montazeri has written about over time.
Heart Diseases, 2 publications between 2014 and 2014, average publication date August 2014. Breast Neoplasms, Male, 1 publications between 2014 and 2014, average publication date October 2014. Protein Kinase Inhibitors, 1 publications between 2019 and 2019, average publication date December 2019. Carcinoma, Transitional Cell, 2 publications between 2019 and 2020, average publication date June 2020. Pyrazoles, 2 publications between 2019 and 2020, average publication date June 2020. Quinoxalines, 2 publications between 2019 and 2020, average publication date June 2020. Urinary Bladder Neoplasms, 3 publications between 2019 and 2021, average publication date October 2020. Molecular Targeted Therapy, 1 publications between 2020 and 2020, average publication date December 2020. Antineoplastic Combined Chemotherapy Protocols, 1 publications between 2021 and 2021, average publication date June 2021. Cisplatin, 1 publications between 2021 and 2021, average publication date June 2021. Delivery of Health Care, 1 publications between 2021 and 2021, average publication date June 2021. Deoxycytidine, 1 publications between 2021 and 2021, average publication date June 2021. Doxorubicin, 1 publications between 2021 and 2021, average publication date June 2021. Methotrexate, 1 publications between 2021 and 2021, average publication date June 2021. Neoadjuvant Therapy, 1 publications between 2021 and 2021, average publication date June 2021. Vinblastine, 1 publications between 2021 and 2021, average publication date June 2021. Skin Neoplasms, 1 publications between 2023 and 2023, average publication date February 2023. Melanoma, 3 publications between 2023 and 2024, average publication date September 2023. Uveal Neoplasms, 1 publications between 2024 and 2024, average publication date December 2023.

To see the data from this visualization as text, click here.
Montazeri's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (49)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.